Goosefoot (Chenopodium berlandieri)

Goosefoot (Chenopodium berlandieri) is a wild edible plant rich in flavonoids, saponins, and polyphenolic compounds that modulate inflammatory pathways by inhibiting COX-2 enzyme activity and suppressing pro-inflammatory cytokines. Its liposomal extracts have demonstrated enhanced intracellular antioxidant delivery, suggesting potential utility in oxidative stress-related conditions.

Origin & History

Goosefoot (Chenopodium berlandieri), also known as huauzontle, is an annual plant from the Amaranthaceae family, native to North America and Mexico. Domesticated in Mesoamerica, it is a pseudocereal closely related to quinoa, valued for its nutrient-dense grains.[1][3][4] It is typically processed from raw or sprouted grains, or its extracts are prepared for applications like liposomal encapsulation.[1][2]

Historical & Cultural Context

Goosefoot, known as huauzontle, has a history of use as an edible pseudocereal in Mesoamerican diets and has been cultivated for a long time.[1][2] It is considered an important genetic resource for the improvement of its relative, quinoa, but specific applications in traditional medicine systems are not detailed in research.[3][4]

Health Benefits

["\u2022 May reduce inflammation by inhibiting pro-inflammatory cytokines (IL-6, TNF-\u03b1, IL-1\u03b2) and the COX-2 enzyme, based on preliminary in vitro evidence using human dermal fibroblasts.[1]", "\u2022 Exhibits antioxidant activity, with liposomal extracts showing enhanced cellular antioxidant effects in lab settings, potentially helping to mitigate oxidative stress.[1]", "\u2022 May support skin structure by inhibiting enzymes that degrade the extracellular matrix, such as elastase, collagenase, and hyaluronidase, according to in vitro studies.[1]", "\u2022 May modulate immune response by increasing the anti-inflammatory cytokine IL-10, as observed in cell culture experiments.[1]", "\u2022 Demonstrates nitric oxide inhibition in lab models, a mechanism relevant to managing inflammation, with effects enhanced by liposomal delivery.[1]"]

How It Works

Chenopodium berlandieri bioactives, including flavonoids and polyphenols, suppress the NF-κB signaling pathway, thereby reducing transcription of pro-inflammatory mediators IL-6, TNF-α, and IL-1β in human dermal fibroblasts. Simultaneously, plant-derived compounds inhibit the COX-2 enzyme, blocking arachidonic acid conversion to prostaglandins that drive inflammatory cascades. Liposomal encapsulation of its extracts has been shown to improve intracellular bioavailability of antioxidants, likely through enhanced membrane fusion and cytosolic delivery of reactive oxygen species (ROS) scavengers.

Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses for Chenopodium berlandieri were identified in the available research.[1][2][3][4][5] The current scientific evidence is limited to in vitro (cell-based) studies investigating its antioxidant and anti-inflammatory properties.[1]

Clinical Summary

Current evidence for Chenopodium berlandieri is limited to preliminary in vitro studies, including cell-based assays using human dermal fibroblasts that demonstrated statistically significant reductions in IL-6, TNF-α, IL-1β, and COX-2 activity. Liposomal extract formulations showed superior cellular antioxidant uptake compared to unencapsulated extracts in controlled laboratory conditions. No human clinical trials, animal studies with quantified outcomes, or randomized controlled trials have been published as of the available data, meaning efficacy in living organisms remains unestablished. The evidence base is early-stage and insufficient to support therapeutic dosing recommendations.

Nutritional Profile

Goosefoot (Chenopodium berlandieri) is a nutrient-dense leafy green and pseudocereal closely related to quinoa and lamb's quarters. **Macronutrients (per 100 g raw leaves, approximate):** Energy: 35–43 kcal; Protein: 4.2–5.2 g (notably high for a leafy green, containing essential amino acids including lysine and methionine); Carbohydrates: 5.5–7.3 g (including ~2.1–3.5 g dietary fiber); Fat: 0.7–1.0 g. **Seeds/grain (per 100 g dried):** Energy: ~350–370 kcal; Protein: 13–17 g; Carbohydrates: 58–65 g; Fat: 4–6 g; Fiber: 6–9 g. **Micronutrients (leaves, per 100 g):** Vitamin A (as β-carotene): 5,800–6,100 µg RAE (very high; bioavailability enhanced with dietary fat); Vitamin C: 65–80 mg; Vitamin K: ~250–300 µg; Folate (B9): ~30–50 µg; Riboflavin (B2): ~0.3 mg; Calcium: 300–410 mg (bioavailability reduced by co-occurring oxalates — estimated ~15–25% absorption); Iron: 3.2–4.2 mg (non-heme form; absorption improved with concurrent vitamin C intake); Magnesium: 70–95 mg; Potassium: 450–550 mg; Phosphorus: 60–80 mg; Zinc: 0.7–1.1 mg; Manganese: ~0.6–0.9 mg. **Bioactive compounds:** Phenolic acids including gallic acid, ferulic acid, and p-coumaric acid (total phenolics ~15–45 mg GAE/g dry weight depending on plant part and extraction); Flavonoids including kaempferol and quercetin glycosides (~2–8 mg/g dry weight); Betalain-related pigments in some varieties; Saponins present especially in seeds (2–4% dry weight — can be reduced by washing/soaking; may have cholesterol-lowering properties but also act as anti-nutrients); Oxalates: 4–8% dry weight in leaves (significant anti-nutrient — blanching/boiling reduces content by 30–50%, improving calcium and iron bioavailability); Phytates present in seeds (~1–2% dry weight), reducing mineral absorption. **Bioavailability notes:** The high oxalate content in leaves substantially impairs calcium and iron absorption; cooking (especially boiling with water discarded) is recommended to reduce oxalates and improve mineral bioavailability. Fat-soluble vitamins (A, K) are better absorbed when consumed with dietary fat. Seed saponins, while partially anti-nutritional, may confer hypolipidemic benefits. The protein quality of seeds is relatively high for a plant source, with a PDCAAS estimated at 0.7–0.85, comparable to quinoa.

Preparation & Dosage

No clinically studied dosage ranges for Goosefoot are available, as no human trials have been conducted.[1][2] In vitro studies have used oleanolic acid-rich liposomal extracts with over 80% encapsulation efficiency, but this does not translate to a human dose.[1] Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Curcumin, Quercetin, Resveratrol, Vitamin C

Safety & Interactions

Chenopodium berlandieri contains oxalates, which in high dietary quantities may contribute to kidney stone formation in susceptible individuals, particularly those with a history of calcium oxalate urolithiasis. Like related species such as Chenopodium album, it may accumulate nitrates in certain growing conditions, posing a theoretical risk if consumed in large amounts. No formal drug interaction studies exist, but its COX-2 inhibitory activity suggests a theoretical additive effect with NSAIDs or anticoagulants such as warfarin. Pregnant or breastfeeding individuals should avoid concentrated extracts due to the absence of safety data.